The management of Parkinson's syndrome.
D000328:Adult; D000368:Aged; D000547:Amantadine / Q000627:therapeutic use; D001590:Benztropine / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism; D004357:Drug Synergism; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000009:adverse effects / Q000627:therapeutic use; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy / Q000378:metabolism / Q000601:surgery / Q000628:therapy*; D026741:Physical Therapy Modalities; D011613:Psychotherapy; D013238:Stereotaxic Techniques; D013788:Thalamus / Q000601:surgery; D013850:Thinking
D006834:Hydrazines; D010276:Parasympatholytics; D001590:Benztropine; D004295:Dihydroxyphenylalanine; D000547:Amantadine; D004298:Dopamine